<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13120">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00424398</url>
  </required_header>
  <id_info>
    <org_study_id>ISTA-BEPO-CS01</org_study_id>
    <nct_id>NCT00424398</nct_id>
  </id_info>
  <brief_title>Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis</brief_title>
  <official_title>A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is
      effective in the treatment of acute allergic conjunctivitis
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Ocular Itching</measure>
    <time_frame>15 minutes, 8 hours &amp; 16 hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Ocular Itching score: 0=None; 0.5=Intermittent tickle sensation possibly localized in the corner of the eye; 1.0=Intermittent tickle sensation involving more than the corner of the eye; 1.5=Intermittent all-over tickling sensation; 2.0=Mild continuous itch (can be localized) without desire to rub; 2.5=Moderate, diffuse continuous itch with desire to rub; 3.0=Severe itch with desire to rub; 3.5=Severe itch improved with minimal rubbing; 4.0=Incapacitating itch with irresistible urge to rub</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Redness</measure>
    <time_frame>15 minutes, 8 hours &amp; 16 hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Conjunctival Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ciliary Redness</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Ciliary Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episcleral Redness</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Episcleral Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chemosis</measure>
    <time_frame>15 Minutes, 8 Hours &amp; s6 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Chemosis score: 0 = None; 1.0 = Mild-Detectable only by slit lamp beam; definite separation of conjunctiva from sclera; 2.0 = Moderate-Visible in normal room light; more diffuse edema; 3.0 = Severe-Conjunctival billowing at the limbus; very diffuse and noticeable; 4.0 = Extremely Severe-Overall ballooning of conjunctiva</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rhinorrhea (Runny Nose)</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Rhinorrhea score: 0 = None; 1.0 = Mild-Sensation of nasal mucus flowing down nasal passage; no discharge present; 2.0 = Moderate-May be associated with post-nasal drip; nasal mucus flow more pronounced; will need to blow nose soon; 3.0 = Moderate/Severe-Nasal mucus discharge requiring occasional wiping with Kleenex; 4.0 = Severe-Uncontrolled nasal discharge; requiring frequent wiping and blowing nose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Pruritus (Itchy Nose)</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Nasal Pruritus score: 0 = None; 1.0 = Mild-An intermittent tickle sensation; 2.0 = Moderate-A mild continuous itch; 3.0 = Moderate/Severe-A severe itch with desire to rub; 4.0 = Severe-Incapacitating itch with an irresistible urge to rub</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ear or Palate Pruritus (Itchy Ear or Palate)</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Ear or Palate Pruritus score: 0 = None; 1.0 = Mild-An intermittent tickle sensation; 2.0 = Moderate-A mild continuous itch; 3.0 = Moderate/Severe-A severe itch with desire to rub; 4.0 = Severe-Incapacitating itch with an irresistible urge to rub</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Congestion</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Nasal Congestion score: 0 = None-Breathes freely; 1.0 = Mild-Breathes with difficulty; 2.0 = Moderate-One nostril partially blocked; 3.0 = Moderate/Severe-Both nostrils partially blocked or one nostril completely blocked and the other nostril partially blocked; 4.0 = Severe-Both nostrils completely blocked</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tearing</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percent of Eyes with Tearing. Scored as absent or present</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular Mucus Discharge</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percent of Eyes with Ocular Mucus Discharge. Scored as absent or present</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eyelid Swelling</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Eyelid Swelling score: 0 = None; 1.0 = Mild-Detectable swelling of lower and/or upper lid; 2.0 = Moderate-Definite swelling of lower and/or upper lid; 3.0 = Severe-Swelling of lower and/or upper lid to the point that there is a decrease in the space between your upper and lower lids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Nasal Symptom</measure>
    <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total Nasal Symptom score (Composite of Rhinorrhea, Nasal Pruritus, Ear or Palate Pruritus, and Nasal Congestion): 0 = None; 1.0 = Mild; 2.0 = Moderate; 3.0 = Moderate/Severe; 4.0 = Severe</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">107</enrollment>
  <condition>Conjunctivitis, Allergic</condition>
  <arm_group>
    <arm_group_label>Bepreve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bepotastine Besilate Ophthalmic Solution 1.5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sterile ophthalmic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bepotastine Besilate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sterile ophthalmic solution 1.0%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bepreve</intervention_name>
    <description>sterile ophthalmic solution</description>
    <arm_group_label>Bepreve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>sterile ophthalmic solution</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bepotastine Besilate</intervention_name>
    <description>sterile ophthalmic solution</description>
    <arm_group_label>Bepotastine Besilate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 10 years of age &amp; either sex, any race

          -  Willing and able to follow all instructions and attend all study visits

          -  Positive history of ocular allergies

        Exclusion Criteria:

          -  Have planned surgery during trial period

          -  Female currently pregnant, planning a pregnancy, or lactating
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jon Williams, PhD</last_name>
    <role>Study Director</role>
    <affiliation>ISTA Pharmaceuticals, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ISTA Pharmaceuticals, Inc.</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92630</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 13, 2013</lastchanged_date>
  <firstreceived_date>January 17, 2007</firstreceived_date>
  <firstreceived_results_date>October 8, 2009</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="P3">
          <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject met exclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="B3">
          <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="35"/>
                <measurement group_id="B2" value="36"/>
                <measurement group_id="B3" value="36"/>
                <measurement group_id="B4" value="107"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="3"/>
                <measurement group_id="B4" value="7"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="33"/>
                <measurement group_id="B2" value="34"/>
                <measurement group_id="B3" value="33"/>
                <measurement group_id="B4" value="100"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="44.3" spread="16.0"/>
                <measurement group_id="B2" value="40.9" spread="11.4"/>
                <measurement group_id="B3" value="39.9" spread="15.2"/>
                <measurement group_id="B4" value="41.7" spread="14.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="18"/>
                <measurement group_id="B2" value="17"/>
                <measurement group_id="B3" value="14"/>
                <measurement group_id="B4" value="49"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="22"/>
                <measurement group_id="B4" value="58"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ocular Itching</title>
        <description>Ocular Itching score: 0=None; 0.5=Intermittent tickle sensation possibly localized in the corner of the eye; 1.0=Intermittent tickle sensation involving more than the corner of the eye; 1.5=Intermittent all-over tickling sensation; 2.0=Mild continuous itch (can be localized) without desire to rub; 2.5=Moderate, diffuse continuous itch with desire to rub; 3.0=Severe itch with desire to rub; 3.5=Severe itch improved with minimal rubbing; 4.0=Incapacitating itch with irresistible urge to rub</description>
        <time_frame>15 minutes, 8 hours &amp; 16 hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ocular Itching</title>
            <description>Ocular Itching score: 0=None; 0.5=Intermittent tickle sensation possibly localized in the corner of the eye; 1.0=Intermittent tickle sensation involving more than the corner of the eye; 1.5=Intermittent all-over tickling sensation; 2.0=Mild continuous itch (can be localized) without desire to rub; 2.5=Moderate, diffuse continuous itch with desire to rub; 3.0=Severe itch with desire to rub; 3.5=Severe itch improved with minimal rubbing; 4.0=Incapacitating itch with irresistible urge to rub</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 3 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.8"/>
                  <measurement group_id="O3" value="0.6" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 5 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="0.9"/>
                  <measurement group_id="O2" value="2.1" spread="0.8"/>
                  <measurement group_id="O3" value="0.7" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="0.9"/>
                  <measurement group_id="O2" value="2.0" spread="0.7"/>
                  <measurement group_id="O3" value="0.7" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 3 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="0.9"/>
                  <measurement group_id="O2" value="2.0" spread="0.7"/>
                  <measurement group_id="O3" value="1.2" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 5 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.9" spread="1.0"/>
                  <measurement group_id="O2" value="2.3" spread="0.7"/>
                  <measurement group_id="O3" value="1.3" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.9" spread="1.0"/>
                  <measurement group_id="O2" value="2.2" spread="0.8"/>
                  <measurement group_id="O3" value="1.3" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 3 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="1.0"/>
                  <measurement group_id="O2" value="2.1" spread="0.9"/>
                  <measurement group_id="O3" value="1.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 5 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.1"/>
                  <measurement group_id="O2" value="2.4" spread="0.8"/>
                  <measurement group_id="O3" value="1.6" spread="0.9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.0"/>
                  <measurement group_id="O2" value="2.3" spread="0.8"/>
                  <measurement group_id="O3" value="1.4" spread="1.0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Redness</title>
        <description>Conjunctival Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
        <time_frame>15 minutes, 8 hours &amp; 16 hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Conjunctival Redness</title>
            <description>Conjunctival Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.1" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.7" spread="0.8"/>
                  <measurement group_id="O2" value="2.1" spread="0.6"/>
                  <measurement group_id="O3" value="1.5" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="2.0" spread="0.6"/>
                  <measurement group_id="O3" value="1.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="0.7"/>
                  <measurement group_id="O2" value="1.7" spread="0.7"/>
                  <measurement group_id="O3" value="1.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.6" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.7"/>
                  <measurement group_id="O3" value="1.6" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.7" spread="0.5"/>
                  <measurement group_id="O2" value="1.8" spread="0.6"/>
                  <measurement group_id="O3" value="1.4" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="0.6"/>
                  <measurement group_id="O2" value="1.8" spread="0.6"/>
                  <measurement group_id="O3" value="1.5" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="0.6"/>
                  <measurement group_id="O2" value="1.7" spread="0.6"/>
                  <measurement group_id="O3" value="1.5" spread="0.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ciliary Redness</title>
        <description>Ciliary Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ciliary Redness</title>
            <description>Ciliary Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="0.9"/>
                  <measurement group_id="O2" value="1.7" spread="0.6"/>
                  <measurement group_id="O3" value="0.9" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="0.9"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.3" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="1.8" spread="0.7"/>
                  <measurement group_id="O3" value="1.3" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="0.8"/>
                  <measurement group_id="O2" value="1.5" spread="0.7"/>
                  <measurement group_id="O3" value="1.2" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="0.9"/>
                  <measurement group_id="O2" value="1.7" spread="0.7"/>
                  <measurement group_id="O3" value="1.5" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="0.9"/>
                  <measurement group_id="O2" value="1.7" spread="0.7"/>
                  <measurement group_id="O3" value="1.4" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.7"/>
                  <measurement group_id="O2" value="1.7" spread="0.6"/>
                  <measurement group_id="O3" value="1.3" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="0.7"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.5" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minute post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.7" spread="0.7"/>
                  <measurement group_id="O2" value="1.8" spread="0.7"/>
                  <measurement group_id="O3" value="1.4" spread="0.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Episcleral Redness</title>
        <description>Episcleral Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Episcleral Redness</title>
            <description>Episcleral Redness score: 0=None; 1.0=Mild-Slightly dilated blood vessels; color of vessels typically pink; 2.0=Moderate-More apparent dilation of blood vessels; vessel color more intense (redder); 3.0=Severe-Numerous, obvious dilated blood vessels; absence of chemosis color is deep red, presence of chemosis may be less red or pink; 4.0=Extremely Severe-Large, numerous dilated blood vessels characterized by severe deep red color regardless of chemosis grade</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.1" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="2.1" spread="0.6"/>
                  <measurement group_id="O3" value="1.5" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="2.0" spread="0.7"/>
                  <measurement group_id="O3" value="1.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="0.7"/>
                  <measurement group_id="O2" value="1.7" spread="0.7"/>
                  <measurement group_id="O3" value="1.4" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.7" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="0.8"/>
                  <measurement group_id="O2" value="1.9" spread="0.7"/>
                  <measurement group_id="O3" value="1.6" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="0.5"/>
                  <measurement group_id="O2" value="2.0" spread="0.5"/>
                  <measurement group_id="O3" value="1.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="0.7"/>
                  <measurement group_id="O2" value="2.0" spread="0.5"/>
                  <measurement group_id="O3" value="1.6" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-cose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="0.6"/>
                  <measurement group_id="O2" value="1.9" spread="0.6"/>
                  <measurement group_id="O3" value="1.5" spread="0.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chemosis</title>
        <description>Chemosis score: 0 = None; 1.0 = Mild-Detectable only by slit lamp beam; definite separation of conjunctiva from sclera; 2.0 = Moderate-Visible in normal room light; more diffuse edema; 3.0 = Severe-Conjunctival billowing at the limbus; very diffuse and noticeable; 4.0 = Extremely Severe-Overall ballooning of conjunctiva</description>
        <time_frame>15 Minutes, 8 Hours &amp; s6 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Chemosis</title>
            <description>Chemosis score: 0 = None; 1.0 = Mild-Detectable only by slit lamp beam; definite separation of conjunctiva from sclera; 2.0 = Moderate-Visible in normal room light; more diffuse edema; 3.0 = Severe-Conjunctival billowing at the limbus; very diffuse and noticeable; 4.0 = Extremely Severe-Overall ballooning of conjunctiva</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.3"/>
                  <measurement group_id="O2" value="0.7" spread="0.5"/>
                  <measurement group_id="O3" value="0.4" spread="0.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="0.5"/>
                  <measurement group_id="O2" value="0.9" spread="0.6"/>
                  <measurement group_id="O3" value="0.5" spread="0.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.3"/>
                  <measurement group_id="O2" value="0.8" spread="0.6"/>
                  <measurement group_id="O3" value="0.5" spread="0.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.5"/>
                  <measurement group_id="O2" value="0.7" spread="0.5"/>
                  <measurement group_id="O3" value="0.5" spread="0.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="0.7"/>
                  <measurement group_id="O2" value="0.9" spread="0.6"/>
                  <measurement group_id="O3" value="0.7" spread="0.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours psot-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="0.7"/>
                  <measurement group_id="O2" value="0.9" spread="0.6"/>
                  <measurement group_id="O3" value="0.8" spread="0.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="0.5"/>
                  <measurement group_id="O2" value="0.9" spread="0.4"/>
                  <measurement group_id="O3" value="0.6" spread="0.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.9" spread="0.5"/>
                  <measurement group_id="O2" value="1.1" spread="0.5"/>
                  <measurement group_id="O3" value="0.8" spread="0.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.9" spread="0.6"/>
                  <measurement group_id="O2" value="1.1" spread="0.6"/>
                  <measurement group_id="O3" value="0.8" spread="0.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rhinorrhea (Runny Nose)</title>
        <description>Rhinorrhea score: 0 = None; 1.0 = Mild-Sensation of nasal mucus flowing down nasal passage; no discharge present; 2.0 = Moderate-May be associated with post-nasal drip; nasal mucus flow more pronounced; will need to blow nose soon; 3.0 = Moderate/Severe-Nasal mucus discharge requiring occasional wiping with Kleenex; 4.0 = Severe-Uncontrolled nasal discharge; requiring frequent wiping and blowing nose</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Rhinorrhea (Runny Nose)</title>
            <description>Rhinorrhea score: 0 = None; 1.0 = Mild-Sensation of nasal mucus flowing down nasal passage; no discharge present; 2.0 = Moderate-May be associated with post-nasal drip; nasal mucus flow more pronounced; will need to blow nose soon; 3.0 = Moderate/Severe-Nasal mucus discharge requiring occasional wiping with Kleenex; 4.0 = Severe-Uncontrolled nasal discharge; requiring frequent wiping and blowing nose</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.8"/>
                  <measurement group_id="O2" value="0.9" spread="1.0"/>
                  <measurement group_id="O3" value="0.1" spread="0.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.9"/>
                  <measurement group_id="O2" value="1.1" spread="1.0"/>
                  <measurement group_id="O3" value="0.2" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.8"/>
                  <measurement group_id="O2" value="0.9" spread="1.1"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.5"/>
                  <measurement group_id="O2" value="0.9" spread="1.0"/>
                  <measurement group_id="O3" value="0.3" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.6"/>
                  <measurement group_id="O2" value="1.5" spread="1.2"/>
                  <measurement group_id="O3" value="0.5" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.6"/>
                  <measurement group_id="O2" value="1.3" spread="1.3"/>
                  <measurement group_id="O3" value="0.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.7"/>
                  <measurement group_id="O2" value="1.0" spread="1.0"/>
                  <measurement group_id="O3" value="0.4" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="0.8"/>
                  <measurement group_id="O2" value="1.4" spread="1.1"/>
                  <measurement group_id="O3" value="0.8" spread="0.9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="0.9"/>
                  <measurement group_id="O2" value="1.2" spread="1.2"/>
                  <measurement group_id="O3" value="0.8" spread="1.0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nasal Pruritus (Itchy Nose)</title>
        <description>Nasal Pruritus score: 0 = None; 1.0 = Mild-An intermittent tickle sensation; 2.0 = Moderate-A mild continuous itch; 3.0 = Moderate/Severe-A severe itch with desire to rub; 4.0 = Severe-Incapacitating itch with an irresistible urge to rub</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Nasal Pruritus (Itchy Nose)</title>
            <description>Nasal Pruritus score: 0 = None; 1.0 = Mild-An intermittent tickle sensation; 2.0 = Moderate-A mild continuous itch; 3.0 = Moderate/Severe-A severe itch with desire to rub; 4.0 = Severe-Incapacitating itch with an irresistible urge to rub</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.7"/>
                  <measurement group_id="O2" value="0.7" spread="0.8"/>
                  <measurement group_id="O3" value="0.1" spread="0.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.6"/>
                  <measurement group_id="O2" value="0.9" spread="0.8"/>
                  <measurement group_id="O3" value="0.2" spread="0.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.6"/>
                  <measurement group_id="O2" value="0.6" spread="0.8"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.1" spread="0.4"/>
                  <measurement group_id="O2" value="0.6" spread="0.9"/>
                  <measurement group_id="O3" value="0.3" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.5"/>
                  <measurement group_id="O2" value="0.9" spread="1.1"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.6"/>
                  <measurement group_id="O2" value="0.8" spread="1.1"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.7"/>
                  <measurement group_id="O2" value="0.8" spread="1.0"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.9"/>
                  <measurement group_id="O2" value="0.9" spread="1.1"/>
                  <measurement group_id="O3" value="0.4" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.9"/>
                  <measurement group_id="O2" value="0.8" spread="1.1"/>
                  <measurement group_id="O3" value="0.4" spread="0.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ear or Palate Pruritus (Itchy Ear or Palate)</title>
        <description>Ear or Palate Pruritus score: 0 = None; 1.0 = Mild-An intermittent tickle sensation; 2.0 = Moderate-A mild continuous itch; 3.0 = Moderate/Severe-A severe itch with desire to rub; 4.0 = Severe-Incapacitating itch with an irresistible urge to rub</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ear or Palate Pruritus (Itchy Ear or Palate)</title>
            <description>Ear or Palate Pruritus score: 0 = None; 1.0 = Mild-An intermittent tickle sensation; 2.0 = Moderate-A mild continuous itch; 3.0 = Moderate/Severe-A severe itch with desire to rub; 4.0 = Severe-Incapacitating itch with an irresistible urge to rub</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.7"/>
                  <measurement group_id="O2" value="0.6" spread="0.9"/>
                  <measurement group_id="O3" value="0.1" spread="0.2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="0.9"/>
                  <measurement group_id="O2" value="0.9" spread="1.0"/>
                  <measurement group_id="O3" value="0.2" spread="0.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="0.9"/>
                  <measurement group_id="O2" value="0.9" spread="1.0"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.5"/>
                  <measurement group_id="O2" value="0.6" spread="0.9"/>
                  <measurement group_id="O3" value="0.4" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.9"/>
                  <measurement group_id="O2" value="1.2" spread="1.2"/>
                  <measurement group_id="O3" value="0.4" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.8"/>
                  <measurement group_id="O2" value="0.9" spread="1.1"/>
                  <measurement group_id="O3" value="0.5" spread="0.9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.7"/>
                  <measurement group_id="O2" value="0.6" spread="0.9"/>
                  <measurement group_id="O3" value="0.3" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.0"/>
                  <measurement group_id="O2" value="1.0" spread="1.2"/>
                  <measurement group_id="O3" value="0.8" spread="1.2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.0"/>
                  <measurement group_id="O2" value="0.9" spread="1.2"/>
                  <measurement group_id="O3" value="0.8" spread="1.1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nasal Congestion</title>
        <description>Nasal Congestion score: 0 = None-Breathes freely; 1.0 = Mild-Breathes with difficulty; 2.0 = Moderate-One nostril partially blocked; 3.0 = Moderate/Severe-Both nostrils partially blocked or one nostril completely blocked and the other nostril partially blocked; 4.0 = Severe-Both nostrils completely blocked</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Nasal Congestion</title>
            <description>Nasal Congestion score: 0 = None-Breathes freely; 1.0 = Mild-Breathes with difficulty; 2.0 = Moderate-One nostril partially blocked; 3.0 = Moderate/Severe-Both nostrils partially blocked or one nostril completely blocked and the other nostril partially blocked; 4.0 = Severe-Both nostrils completely blocked</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="1.0"/>
                  <measurement group_id="O2" value="0.9" spread="1.0"/>
                  <measurement group_id="O3" value="0.2" spread="0.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.9"/>
                  <measurement group_id="O2" value="1.1" spread="1.2"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.9"/>
                  <measurement group_id="O2" value="1.2" spread="1.1"/>
                  <measurement group_id="O3" value="0.3" spread="0.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.5"/>
                  <measurement group_id="O2" value="0.9" spread="1.0"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.8"/>
                  <measurement group_id="O2" value="1.2" spread="1.2"/>
                  <measurement group_id="O3" value="0.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.8"/>
                  <measurement group_id="O2" value="1.1" spread="1.2"/>
                  <measurement group_id="O3" value="0.4" spread="0.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.7"/>
                  <measurement group_id="O2" value="1.0" spread="1.0"/>
                  <measurement group_id="O3" value="0.4" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.0"/>
                  <measurement group_id="O2" value="1.3" spread="1.1"/>
                  <measurement group_id="O3" value="0.8" spread="1.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.0"/>
                  <measurement group_id="O2" value="1.2" spread="1.2"/>
                  <measurement group_id="O3" value="0.8" spread="1.0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tearing</title>
        <description>Percent of Eyes with Tearing. Scored as absent or present</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Tearing</title>
            <description>Percent of Eyes with Tearing. Scored as absent or present</description>
            <units>Percent of Eyes with Tearing Present</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="14.3"/>
                  <measurement group_id="O2" value="43.1"/>
                  <measurement group_id="O3" value="6.9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="17.1"/>
                  <measurement group_id="O2" value="34.7"/>
                  <measurement group_id="O3" value="9.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="17.1"/>
                  <measurement group_id="O2" value="38.9"/>
                  <measurement group_id="O3" value="11.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="12.9"/>
                  <measurement group_id="O2" value="50.0"/>
                  <measurement group_id="O3" value="13.9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="14.3"/>
                  <measurement group_id="O2" value="56.9"/>
                  <measurement group_id="O3" value="16.7"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="12.9"/>
                  <measurement group_id="O2" value="40.3"/>
                  <measurement group_id="O3" value="15.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="11.4"/>
                  <measurement group_id="O2" value="43.1"/>
                  <measurement group_id="O3" value="23.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="15.7"/>
                  <measurement group_id="O2" value="44.4"/>
                  <measurement group_id="O3" value="19.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="15.7"/>
                  <measurement group_id="O2" value="34.7"/>
                  <measurement group_id="O3" value="23.6"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ocular Mucus Discharge</title>
        <description>Percent of Eyes with Ocular Mucus Discharge. Scored as absent or present</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ocular Mucus Discharge</title>
            <description>Percent of Eyes with Ocular Mucus Discharge. Scored as absent or present</description>
            <units>Percent of Eyes with OMD Present</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="1.4"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.9"/>
                  <measurement group_id="O2" value="0.0"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.9"/>
                  <measurement group_id="O2" value="0.0"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="1.4"/>
                  <measurement group_id="O3" value="1.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="2.8"/>
                  <measurement group_id="O3" value="1.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="2.8"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="2.8"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="5.6"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.0"/>
                  <measurement group_id="O2" value="5.6"/>
                  <measurement group_id="O3" value="0.0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Eyelid Swelling</title>
        <description>Eyelid Swelling score: 0 = None; 1.0 = Mild-Detectable swelling of lower and/or upper lid; 2.0 = Moderate-Definite swelling of lower and/or upper lid; 3.0 = Severe-Swelling of lower and/or upper lid to the point that there is a decrease in the space between your upper and lower lids</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Eyelid Swelling</title>
            <description>Eyelid Swelling score: 0 = None; 1.0 = Mild-Detectable swelling of lower and/or upper lid; 2.0 = Moderate-Definite swelling of lower and/or upper lid; 3.0 = Severe-Swelling of lower and/or upper lid to the point that there is a decrease in the space between your upper and lower lids</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.5"/>
                  <measurement group_id="O2" value="0.7" spread="0.7"/>
                  <measurement group_id="O3" value="0.2" spread="0.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.5"/>
                  <measurement group_id="O2" value="0.8" spread="0.7"/>
                  <measurement group_id="O3" value="0.2" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.3" spread="0.5"/>
                  <measurement group_id="O2" value="0.9" spread="0.7"/>
                  <measurement group_id="O3" value="0.3" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.4" spread="0.7"/>
                  <measurement group_id="O2" value="0.7" spread="0.7"/>
                  <measurement group_id="O3" value="0.3" spread="0.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.8"/>
                  <measurement group_id="O2" value="0.9" spread="0.9"/>
                  <measurement group_id="O3" value="0.4" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.7"/>
                  <measurement group_id="O2" value="0.9" spread="0.9"/>
                  <measurement group_id="O3" value="0.4" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.6"/>
                  <measurement group_id="O2" value="0.7" spread="0.7"/>
                  <measurement group_id="O3" value="0.3" spread="0.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.7"/>
                  <measurement group_id="O2" value="0.9" spread="0.9"/>
                  <measurement group_id="O3" value="0.4" spread="0.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.7"/>
                  <measurement group_id="O2" value="0.8" spread="0.8"/>
                  <measurement group_id="O3" value="0.5" spread="0.6"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Nasal Symptom</title>
        <description>Total Nasal Symptom score (Composite of Rhinorrhea, Nasal Pruritus, Ear or Palate Pruritus, and Nasal Congestion): 0 = None; 1.0 = Mild; 2.0 = Moderate; 3.0 = Moderate/Severe; 4.0 = Severe</description>
        <time_frame>15 Minutes, 8 Hours &amp; 16 Hours post-dose from Conjunctival Allergen Challenge (CAC) Model</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
          <group group_id="O3">
            <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
            <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="35"/>
                  <measurement group_id="O2" value="36"/>
                  <measurement group_id="O3" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Total Nasal Symptom</title>
            <description>Total Nasal Symptom score (Composite of Rhinorrhea, Nasal Pruritus, Ear or Palate Pruritus, and Nasal Congestion): 0 = None; 1.0 = Mild; 2.0 = Moderate; 3.0 = Moderate/Severe; 4.0 = Severe</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>15 Minutes post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="2.2"/>
                  <measurement group_id="O2" value="3.2" spread="3.1"/>
                  <measurement group_id="O3" value="0.4" spread="0.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.7" spread="2.2"/>
                  <measurement group_id="O2" value="4.0" spread="3.4"/>
                  <measurement group_id="O3" value="0.9" spread="1.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 Minutes post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="2.2"/>
                  <measurement group_id="O2" value="3.6" spread="3.2"/>
                  <measurement group_id="O3" value="1.0" spread="1.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.6"/>
                  <measurement group_id="O2" value="2.9" spread="3.1"/>
                  <measurement group_id="O3" value="1.3" spread="2.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="2.2"/>
                  <measurement group_id="O2" value="4.8" spread="4.0"/>
                  <measurement group_id="O3" value="1.6" spread="2.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>8 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="2.4"/>
                  <measurement group_id="O2" value="4.0" spread="4.0"/>
                  <measurement group_id="O3" value="1.5" spread="2.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 7 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="2.0"/>
                  <measurement group_id="O2" value="3.4" spread="3.2"/>
                  <measurement group_id="O3" value="1.3" spread="2.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 15 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.5" spread="2.9"/>
                  <measurement group_id="O2" value="4.5" spread="4.0"/>
                  <measurement group_id="O3" value="2.7" spread="3.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>16 Hours post-dose: 20 Minutes post CAC</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.6" spread="3.1"/>
                  <measurement group_id="O2" value="4.0" spread="4.3"/>
                  <measurement group_id="O3" value="2.8" spread="3.3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
        <group group_id="E3">
          <title>Bepotastine Besilate Ophthalmic Solution 1.0%</title>
          <description>1 drop, both eyes at 3 different time points post-CAC within 3 different time points post-dose, for a total of 9 separate time points</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye Irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Mild Taste</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Agreement is between contract research organization and third parties on behalf of ISTA Pharmaceuticals, Inc.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vice President, Clinical Research &amp; Medical Affairs</name_or_title>
      <organization>ISTA Pharmaceuticals, Inc.</organization>
      <phone>949-788-6000</phone>
      <email>tmcnamara@istavision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
